{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:11:06Z","timestamp":1788865866403,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijantimicag.2026.107906","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:51:06Z","timestamp":1783353066000},"page":"107906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and therapeutic dilemmas in nocardiosis: Insights from a case series"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1123-7991","authenticated-orcid":false,"given":"Hidemasa","family":"Akazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinnosuke","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuma","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakura","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Iio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5086-1891","authenticated-orcid":false,"given":"Hideharu","family":"Hagiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107906_bib0001","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00027-21","article-title":"Updated review on Nocardia species: 2006-2021","volume":"35","author":"Traxler","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0002","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1093\/cid\/ciae643","article-title":"State-of-the-art review: modern approach to nocardiosis-diagnosis, management, and uncertainties","volume":"80","author":"Yetmar","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01890-21","article-title":"Nocardiosis in Japan: a multicentric retrospective cohort study","volume":"66","author":"Takamatsu","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0004","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/cid\/ciab866","article-title":"Nocardia infections in hematopoietic cell transplant recipients: a multicenter international retrospective study of the infectious diseases working party of the European society for blood and marrow transplantation","volume":"75","author":"Averbuch","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40272-013-0017-5","article-title":"Pharmacokinetics of antibacterial agents in the CSF of children and adolescents","volume":"15","author":"Sullins","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0006","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/j.1875-9114.1996.tb03649.x","article-title":"Oral absorption of trimethoprim-sulfamethoxazole in patients with AIDS","volume":"16","author":"Klepser","year":"1996","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0007","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijid.2023.02.023","article-title":"Clinical characteristics, susceptibility profiles, and treatment of nocardiosis: a multicenter retrospective study in 2015-2021","volume":"130","author":"Yang","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0008","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jmii.2022.11.002","article-title":"Clinical manifestations and outcome of nocardiosis and antimicrobial susceptibility of Nocardia species in southern Taiwan, 2011-2021","volume":"56","author":"Yang","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0009","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s15010-024-02323-9","article-title":"Trimethoprim-sulfamethoxazole dosing and outcomes of pulmonary nocardiosis","volume":"53","author":"Yetmar","year":"2025","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0010","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cmi.2020.12.019","article-title":"How do I manage nocardiosis?","volume":"27","author":"Margalit","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0011","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/bcp.70051","article-title":"Safety of sulfamethoxazole-trimethoprim for the treatment of bacterial infection in outpatient settings: a systematic review and meta-analysis with active comparator disproportionality analysis","volume":"91","author":"Preyra","year":"2025","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13669","article-title":"Trimethoprim\/sulfamethoxazole for nocardiosis in solid organ transplant recipients: real-life data from a multicentre retrospective study","volume":"23","author":"Conan","year":"2021","journal-title":"Transpl Infect Dis: Off J Transplant Soc"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0013","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.chest.2023.08.009","article-title":"Low-dose vs conventional-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in patients not infected with HIV: a multicenter, retrospective observational cohort study","volume":"165","author":"Nagai","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0014","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13452","article-title":"Sulfonamides without trimethoprim in the treatment of Nocardia infections: a case report and literature review","volume":"23","author":"Root","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0015","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jiac.2024.04.008","article-title":"Successful maintenance treatment of disseminated nocardiosis with cerebral abscess in a severely immunocompromised patient allergic to trimethoprim-sulfamethoxazole using moxifloxacin and high-dose minocycline: a case report","volume":"30","author":"Yamamoto","year":"2024","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0016","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jinf.2014.08.010","article-title":"Experience with linezolid for the treatment of nocardiosis in organ transplant recipients","volume":"70","author":"De La Cruz","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0017","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1038\/s41598-024-55916-7","article-title":"In vitro activity of tedizolid against 43 species of Nocardia species","volume":"14","author":"Toyokawa","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0018","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jiac.2022.03.020","article-title":"Long-term use of tedizolid for pulmonary nocardiosis","volume":"28","author":"Chomei","year":"2022","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0019","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/dkae025","article-title":"Linezolid brain penetration in neurointensive care patients","volume":"79","author":"Hosmann","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2019.104420","article-title":"Comparative pharmacokinetics of tedizolid in rat plasma and cerebrospinal fluid","volume":"107","author":"Gu","year":"2019","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10096-007-0413-2","article-title":"In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S rRNA sequencing","volume":"27","author":"Hansen","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0022","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1128\/AAC.01808-10","article-title":"Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species","volume":"55","author":"Lai","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0023","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1093\/jac\/dkaf312","article-title":"Phenotypic and genotypic profiles of clinical isolates of various Nocardia species to carbapenems and fluoroquinolones","volume":"80","author":"Yang","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0024","article-title":"Case Report: nocardia farcinica infectious arthritis and myositis in an immunocompromised host: diagnostic and management challenges","volume":"13","author":"Liu","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0025","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s10156-011-0233-2","article-title":"Nocardia beijingensis pulmonary infection successfully treated with intravenous beta-lactam antibiotics and oral minocycline","volume":"17","author":"Ogawa","year":"2011","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0026","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cmi.2023.10.008","article-title":"Trimethoprim-sulfamethoxazole significantly reduces the risk of nocardiosis in solid organ transplant recipients: systematic review and individual patient data meta-analysis","volume":"30","author":"Passerini","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107906_bib0027","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13509","article-title":"Nocardia infections in solid organ transplantation: guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation","volume":"33","author":"Restrepo","year":"2019","journal-title":"Clin Transpl"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926001937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926001937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:49:33Z","timestamp":1788864573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926001937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0924857926001937"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107906","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and therapeutic dilemmas in nocardiosis: Insights from a case series","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107906"}}